secwatch.observer — SEC 8-K summary
======================================

Issuer:     WEST PHARMACEUTICAL SERVICES INC (WST)
CIK:        0000105770
Form:       8-K
Filed at:   2025-03-11T23:59:59+00:00
Accession:  0000105770-25-000019
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

West Pharma CCO Cindy Reiss-Clark departs; interim lead named
-------------------------------------------------------------

- Cindy Reiss-Clark, SVP and Chief Commercial Officer, departed effective March 7, 2025.
- Interim leadership of commercial responsibilities assumed by Aileen Kinsella, Head of Proprietary Product Sales.
- Company thanked Reiss-Clark for her contributions; no reason for departure disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/105770/000010577025000019/0000105770-25-000019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/105770/000010577025000019/wst-20250307.htm
  HTML page:      https://secwatch.observer/filing/0000105770-25-000019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer